Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).
about
Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesisImmunopathogenesis and neurological manifestations associated to HTLV-1 infectionCiclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesisTreatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted TherapyContribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease?The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study.Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection.Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseasesAltered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease.Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.Electrophysiological analysis shows dizziness as the first symptom in human T cell lymphotropic virus type-associated myelopathy/tropical spastic paraparesis.Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk TestIn contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infectionCyclosporine for the treatment of HLTV-1-induced HAM/TSP: an experience from a case report.Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infectionHTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B GeneCytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of BrazilHTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.Current topics in prevention of human T-cell leukemia virus type i infection: NF-kappa B inhibitors and APOBEC3.Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian childrenClinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study.Standardisation of Western blotting to detect HTLV-1 antibodies synthesised in the central nervous system of HAM/TSP patientsInflammatory manifestations of HTLV-1 and their therapeutic options.Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis.Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients.Downregulation of histone methyltransferase EHMT2 in CD4(+) T-cells may protect HTLV-1-infected individuals against HAM/TSP development.Motor behavioral abnormalities and histopathological findings of Wistar rats inoculated with HTLV-1-infected MT2 cells.Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.Using the International Classification of Functioning, Disability and Health as a tool for analysis of the effect of physical therapy on spasticity in HAM/TSP patients.Home-based exercise program in TSP/HAM individuals: a feasibility and effectiveness study.
P2860
Q21131133-17412295-4DFE-48ED-BD81-A02BCFD894ECQ27026230-28477717-D5AC-4DD2-8EDD-AFA6B96662CFQ28484214-F6F4EBBC-C191-4221-BAD9-689C528ADEB6Q28972318-A6BF3CB4-B4CF-4754-9372-2485D7991B2CQ30446770-842E2B79-5EF0-419C-BD25-5D43CF4769F4Q30913837-242A7332-2FDA-43E0-BD6F-932E7FC38E4AQ33277961-36525990-84DD-49C9-A02A-FB5C11A94BE6Q33573817-899CC8E6-A846-4090-80D9-4D64331E83B1Q33713794-A9349FB2-D74A-4310-A8AF-97B97CB18F2EQ33777159-A57AB737-4A31-46B8-A9B1-EA81E562D5A1Q33983161-06B23F32-DC19-4E1B-9713-481E8BCE55EEQ34257239-19F49B68-57AB-4056-A79F-BE6BD99E0339Q34754386-BAA5F73E-06D4-45D3-915A-14BDB192961DQ35692176-F7EF67C0-7722-4321-8513-16D6236FF3DBQ35975547-686F8CB3-0BDC-42A5-8735-46DC4E8D7C20Q35989638-413D0029-AB1D-4701-859D-84175A52E985Q36060160-44B82168-39CC-42CA-89F6-629C19D67629Q36110061-D7D5A440-C94D-45FB-9C42-AB87388AC458Q36152816-9D783D19-04C5-4989-9BAA-9B0F1B5C735AQ36277748-8162992C-D418-4600-9DF4-CEDF895729F9Q36279205-80C770B9-851A-4A5B-AF46-05CCF9F2A161Q36334037-2B14525B-F9B0-42E2-843B-7E2793CC997AQ36395167-F74B4B4B-886D-464D-A232-CC83F81754B6Q36592313-FD5CCFB8-0F90-461F-80C4-96F54D3A9F86Q36689405-0CD5D1B0-26D4-4E6B-A055-9BE67AECDCE7Q36995018-663B03FA-F2AA-4D58-A0AE-AA4CEEA7CB62Q37198681-E8C0ED39-31A0-4A88-9E03-92AC69D337BDQ37394120-56274B90-05DC-458D-A6D6-02D65E1CF0BBQ37488010-D14E98A3-D140-41E5-AA92-86BB748C05A5Q37498121-1BB62606-FF61-4B4D-802C-A384E91608BBQ37675362-D0F80E6E-BFB3-4395-BB28-A307C90DE7DCQ38262169-FA75B86A-E677-413E-97B9-DCCBA70996ECQ38768079-4965BC6B-0C36-4595-A431-35B6ACB4605AQ38871243-5B813AD3-4D96-42EB-A1E3-8FA8301038B9Q38934680-FC269F31-717B-4514-B594-B5A05E70892BQ38950117-E1444CF5-B931-40AC-826C-95D728D3B717Q38958902-63FFE5D0-D4D3-480F-A309-E53B1B38BD54Q38972538-3A161E3F-A7BB-4542-B6DB-2066106808AEQ38976877-3A6D2C7D-7D62-47E6-AAF4-BAE61B9B1C71Q38997386-912CDCE2-807A-4204-843E-E9E25A8B2FFD
P2860
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Proposal for diagnostic criter ...... sociated myelopathy (TSP/HAM).
@en
type
label
Proposal for diagnostic criter ...... sociated myelopathy (TSP/HAM).
@en
prefLabel
Proposal for diagnostic criter ...... sociated myelopathy (TSP/HAM).
@en
P2093
P356
P1476
Proposal for diagnostic criter ...... ssociated myelopathy (TSP/HAM)
@en
P2093
Carlos M De Castro-Costa
Carlos Remondegui
Eduardo Gotuzzo
Eduardo L M da Silva
Edward L Murphy
Graham P Taylor
Herwig Carton
João G R Ribas
Luis C Rovirosa
P304
P356
10.1089/AID.2006.22.931
P577
2006-10-01T00:00:00Z